Bangladesh
· Delayed Price · Currency is BDT Asiatic Laboratories Statistics
Total Valuation
Asiatic Laboratories has a market cap or net worth of BDT 4.39 billion.
| Market Cap | 4.39B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Asiatic Laboratories has 122.39 million shares outstanding.
| Shares Outstanding | 122.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 55.71% |
| Owned by Institutions (%) | 1.63% |
| Float | 46.08M |
Valuation Ratios
The trailing PE ratio is 9.84.
| PE Ratio | 9.84 |
| Forward PE | n/a |
| PS Ratio | 2.17 |
| PB Ratio | 0.63 |
| P/FCF Ratio | 77.21 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 7.40.
| Current Ratio | 2.73 |
| Quick Ratio | 0.87 |
| Debt / Equity | 7.40 |
| Debt / EBITDA | 0.71 |
| Debt / FCF | 6.46 |
| Interest Coverage | 9.46 |
Financial Efficiency
Return on equity (ROE) is 8.25% and return on invested capital (ROIC) is 6.10%.
| Return on Equity (ROE) | 8.25% |
| Return on Assets (ROA) | 5.48% |
| Return on Capital (ROIC) | 6.10% |
| Revenue Per Employee | 1.88M |
| Profits Per Employee | 416,265 |
| Employee Count | 770 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 2.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 44.81 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 39.56 |
| Average Volume (20 Days) | 1,158,903 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Asiatic Laboratories had revenue of BDT 1.45 billion and earned 320.52 million in profits. Earnings per share was 3.65.
| Revenue | 1.45B |
| Gross Profit | 623.38M |
| Operating Income | 415.51M |
| Pretax Income | 371.48M |
| Net Income | 320.52M |
| EBITDA | 504.70M |
| EBIT | 415.51M |
| Earnings Per Share (EPS) | 3.65 |
Balance Sheet
The company has 8.98 million in cash and 367.80 million in debt, giving a net cash position of -358.81 million or -2.93 per share.
| Cash & Cash Equivalents | 8.98M |
| Total Debt | 367.80M |
| Net Cash | -358.81M |
| Net Cash Per Share | -2.93 |
| Equity (Book Value) | 4.97B |
| Book Value Per Share | 56.61 |
| Working Capital | 399.53M |
Cash Flow
In the last 12 months, operating cash flow was 432.01 million and capital expenditures -375.10 million, giving a free cash flow of 56.91 million.
| Operating Cash Flow | 432.01M |
| Capital Expenditures | -375.10M |
| Free Cash Flow | 56.91M |
| FCF Per Share | 0.46 |
Margins
Gross margin is 42.95%, with operating and profit margins of 28.63% and 22.09%.
| Gross Margin | 42.95% |
| Operating Margin | 28.63% |
| Pretax Margin | 25.60% |
| Profit Margin | 22.09% |
| EBITDA Margin | 34.78% |
| EBIT Margin | 28.63% |
| FCF Margin | 3.92% |
Dividends & Yields
Asiatic Laboratories does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 10.16% |
| FCF Yield | 1.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |